Interaction of clonidine and clonidine analogs with human platelet alpha 2-adrenergic receptors.
Biochim Biophys Acta
; 714(3): 389-94, 1982 Feb 25.
Article
em En
| MEDLINE
| ID: mdl-6120721
ABSTRACT
Several new clonidine analogs were synthesized and their ability to inhibit [3H]phentolamine binding to human platelet alpha 2-adrenergic receptors was tested. The order of potency and calculated dissociation constants for clonidine and its analogs were as follows clonidine (0.020 +/- 0.005 microM) greater than p-aminoclonidine (0.100 +/- 0.010 microM) greater than hydroxy-phenacetyl-aminoclonidine (0.20 +/- 0.03 microM) greater than p-dansyl clonidine (1.00 +/- 0.20 microM) greater than t-boc-tyrosine clonidine (1.80 +/- 0.60 microM). Thus, p-amino substitution reduces alpha 2-adrenergic affinity in the platelet system. The effects of clonidine and its p-amino analogs on platelet adenylate cyclase were also evaluated. This enzyme is inhibited by epinephrine acting via alpha 2-adrenergic receptors. Both clonidine and p-aminoclonidine cause slight inhibition of basal adenylate cyclase and reverse the inhibition induced by epinephrine. These observations indicate that clonidine is a partial agonist for platelet alpha 2-adrenergic receptors.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Plaquetas
/
Receptores Adrenérgicos
/
Receptores Adrenérgicos alfa
/
Clonidina
/
Agonistas alfa-Adrenérgicos
Idioma:
En
Ano de publicação:
1982
Tipo de documento:
Article